
Rheos Medicines
closedA biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.
Employees
Enterprise value
$240—360m
Authorizing premium user...
A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.